Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
University of Zurich |
---|---|
Information provided by: | University of Zurich |
ClinicalTrials.gov Identifier: | NCT00696254 |
The aim of this study is to investigate the effect of general anaesthetics on nerve excitability. We use the method of threshold tracking to measure selected parameters of nerve excitability.
Condition | Intervention | Phase |
---|---|---|
General Anesthesia |
Behavioral: Threshold tracking |
Phase I |
Study Type: | Observational |
Study Design: | Case Control, Prospective |
Official Title: | Impact of General Anaesthetics on Excitability of the Peripheral Sensory Nerve |
Estimated Enrollment: | 40 |
Study Start Date: | March 2008 |
Estimated Study Completion Date: | December 2008 |
Estimated Primary Completion Date: | December 2008 (Final data collection date for primary outcome measure) |
The median nerve of the patients will be stimulated electrically before, during and after the therapy. A computerized threshold-tracking protocol will be used to measure strength-duration time constants (τSD), threshold electrotonus to 100-ms polarizing currents (to measure accommodation) and the recovery cycle of excitability following a conditioning nerve impulse (refractoriness, superexcitability and late subexcitability). The measurements will be made before and after induction of anesthesia.
Ages Eligible for Study: | 18 Years to 75 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Sampling Method: | Probability Sample |
German speaking patients scheduled for surgery under general anaesthesia.
Inclusion criteria:
Exclusion criteria:
Contact: Konrad Maurer, MD | +41 (0)44 255 11 11 | konrad.maurer@usz.ch |
Contact: Donat R Spahn, MD | donat.spahn@usz.ch |
Switzerland | |
University Hospital Zurich | Recruiting |
Zurich, Switzerland | |
Contact: Konrad Maurer, Dr. konrad.maurer@usz.ch | |
Contact: Donat R Spahn, Prof. donat.spahn@usz.ch |
Principal Investigator: | Konrad Maurer, MD | University of Zurich |
Responsible Party: | University Hospital Zurich ( Konrad Maurer ) |
Study ID Numbers: | 5-2008 |
Study First Received: | March 17, 2008 |
Last Updated: | June 11, 2008 |
ClinicalTrials.gov Identifier: | NCT00696254 |
Health Authority: | Switzerland: Swissmedic |